Stay updated on Sabatolimab & Magrolimab Treatment in AML Clinical Trial
Sign up to get notified when there's something new on the Sabatolimab & Magrolimab Treatment in AML Clinical Trial page.

Latest updates to the Sabatolimab & Magrolimab Treatment in AML Clinical Trial page
- Check6 days agoChange DetectedA new revision entry (v3.6.0) has been added to the study record history. The previous revision (v3.5.5) has been removed from the history.SummaryDifference0.5%

- Check13 days agoChange DetectedA new revision entry v3.5.5 is added to the Study Record History, and the previous revision v3.5.4 is removed from the history. This reflects an update to the metadata tracking of the study record.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedRevision: v3.5.4 is now listed as the latest version in the revision history, replacing the previous v3.5.3 entry. This reflects an update to the page's internal versioning information.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page’s version/revision label has been updated from v3.5.2 to v3.5.3, indicating an internal site update rather than a change to the clinical trial record details.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded Revision: v3.5.2 and deleted Revision: v3.5.0 from the study record history.SummaryDifference0.1%

- Check92 days agoChange DetectedThe Record History now shows a new revision entry v3.5.0 and the previous entry v3.4.3 has been removed. No study data or results are changed.SummaryDifference0.1%

Stay in the know with updates to Sabatolimab & Magrolimab Treatment in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sabatolimab & Magrolimab Treatment in AML Clinical Trial page.